The clinical validity of four different low-redundant speech tests was
calculated using four groups of 83 patients with retrocochlear or cen
tral auditory lesions. The speech tests used were: interrupted speech
(7 or 10 interruptions/s) time-compressed speech and filtered speech.
A comparison between patients and age-matched normal-hearing controls
showed that the patients had significantly lower speech recognition sc
ore. The best sensitivity ratings of the tests were between 47% and 80
%, the highest in patients with cerebellopontine angle tumours and tem
poral lobe lesions, and the lowest in vascular brainstem lesions. The
speech tests with the highest sensitivity were 7 interruptions/s and t
ime-compressed speech.